Tina Moore

I just read about it a few weeks ago in an article on Medline, I think it was. And then they referred to an article from a few years back when they were talking about this pen click method, which I've never heard of, where you just dial the pen a certain amount of clicks to get the dose that you're looking for. And based on the amount of clicks, they give you the actual dosage that that would be.

And this is very exciting. This means we can use the pens to microdose and we don't have to be so reliant on the compounded pharmacy versions, nor do we have to do necessarily the vial versions that the two big companies have released that we could consider. If you're getting access to these peptides medications through your insurance and they're paying for it,

And this is very exciting. This means we can use the pens to microdose and we don't have to be so reliant on the compounded pharmacy versions, nor do we have to do necessarily the vial versions that the two big companies have released that we could consider. If you're getting access to these peptides medications through your insurance and they're paying for it,

And this is very exciting. This means we can use the pens to microdose and we don't have to be so reliant on the compounded pharmacy versions, nor do we have to do necessarily the vial versions that the two big companies have released that we could consider. If you're getting access to these peptides medications through your insurance and they're paying for it,

you actually can utilize the pens to give yourself a lower dose. How you want to dose, why you want to dose at a lower dose, what your short-term goals, what your long-term goals, all of that matters and that dictates what I would ever suggest somebody do. I'm never going to suggest

you actually can utilize the pens to give yourself a lower dose. How you want to dose, why you want to dose at a lower dose, what your short-term goals, what your long-term goals, all of that matters and that dictates what I would ever suggest somebody do. I'm never going to suggest

you actually can utilize the pens to give yourself a lower dose. How you want to dose, why you want to dose at a lower dose, what your short-term goals, what your long-term goals, all of that matters and that dictates what I would ever suggest somebody do. I'm never going to suggest

here on the internet that's medical advice on the internet which is ridiculous but inside my course I talk about my clinical rationale as to how and where to start and what that looks like and where do you go from there and talking about cycling or doing different strategies inside of that clinical rationale so

here on the internet that's medical advice on the internet which is ridiculous but inside my course I talk about my clinical rationale as to how and where to start and what that looks like and where do you go from there and talking about cycling or doing different strategies inside of that clinical rationale so

here on the internet that's medical advice on the internet which is ridiculous but inside my course I talk about my clinical rationale as to how and where to start and what that looks like and where do you go from there and talking about cycling or doing different strategies inside of that clinical rationale so

There's more to this and it's a comprehensive treatment plan that allows this one peptide to work. I really don't think putting somebody on a GLP-1 solo is going to be the solution. Again, I don't think it's going to work for very long. Even if they're using it high doses, I don't think it's going to work for very long forever. You have to have a comprehensive treatment plan.

There's more to this and it's a comprehensive treatment plan that allows this one peptide to work. I really don't think putting somebody on a GLP-1 solo is going to be the solution. Again, I don't think it's going to work for very long. Even if they're using it high doses, I don't think it's going to work for very long forever. You have to have a comprehensive treatment plan.

There's more to this and it's a comprehensive treatment plan that allows this one peptide to work. I really don't think putting somebody on a GLP-1 solo is going to be the solution. Again, I don't think it's going to work for very long. Even if they're using it high doses, I don't think it's going to work for very long forever. You have to have a comprehensive treatment plan.

At the very least, you have to be lifting weights and you have to be hitting your protein macros. But there are other peptides. There's HRT, which is hormone replacement therapy. There's a lot of other factors to consider here. And ultimately, the person has to be living an insulin-sensitive lifestyle.

At the very least, you have to be lifting weights and you have to be hitting your protein macros. But there are other peptides. There's HRT, which is hormone replacement therapy. There's a lot of other factors to consider here. And ultimately, the person has to be living an insulin-sensitive lifestyle.

At the very least, you have to be lifting weights and you have to be hitting your protein macros. But there are other peptides. There's HRT, which is hormone replacement therapy. There's a lot of other factors to consider here. And ultimately, the person has to be living an insulin-sensitive lifestyle.

And I go deep into that and what that looks like and how to phase through that, how to phase your patients through that inside my course. I will make sure that the link to this article is in the show notes so you can check it out. Just very exciting that the concept of microdosing has made it to mainstream and it's made it into a medical journal.

And I go deep into that and what that looks like and how to phase through that, how to phase your patients through that inside my course. I will make sure that the link to this article is in the show notes so you can check it out. Just very exciting that the concept of microdosing has made it to mainstream and it's made it into a medical journal.

And I go deep into that and what that looks like and how to phase through that, how to phase your patients through that inside my course. I will make sure that the link to this article is in the show notes so you can check it out. Just very exciting that the concept of microdosing has made it to mainstream and it's made it into a medical journal.

So here we are and I will take a little bit of credit for that. And then booyah to everyone who's ran with this and the doctors who are realizing that a more personalized approach is the way to go whether they're using it for other things or whether they're utilizing it for what it is FDA approved for, which is the on-label use of obesity and type 2 diabetes.